Arisan Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2010-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.arisanthera.com
A Comparison of the Pharmacokinetic Properties of ARN-75039 Tablets With Excipients to Neat ARN-75039 in Hydroxypropyl Methylcellulose (HPMC) Capsules in Healthy Adult Participants Under Fed Conditions
- First Posted Date
- 2025-04-04
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Arisan Therapeutics, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT06911242
- Locations
- 🇺🇸
Frontage, Secaucus, New Jersey, United States
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects
Phase 1
Completed
- Conditions
- Lassa Virus Infection
- Interventions
- Drug: ARN-75039 oral capsulesDrug: Placebo
- First Posted Date
- 2023-02-21
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Arisan Therapeutics, Inc.
- Target Recruit Count
- 94
- Registration Number
- NCT05735249
- Locations
- 🇺🇸
Spaulding Clinical, LLC, West Bend, Wisconsin, United States